TAWNI LEHECKA: Open Payments
NPI 1588223366 · SALINA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$502 in 28 payments from 12 companies in 2025. Trend: 2023 $444 · 2024 $706 · 2025 $502
Food & beverage: $502
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 6 | $92 |
| Dexcom, Inc. | 5 | $87 |
| Biogen, Inc. | 4 | $60 |
| ABBVIE INC. | 3 | $56 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $47 |
| Sumitomo Pharma America, Inc. | 2 | $41 |
| PFIZER INC. | 1 | $24 |
| Pharmacosmos Therapeutics Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $20 |
| Lilly USA, LLC | 1 | $18 |
Products named: Veozah, Dexcom G6 Transmitter, ZURZUVAE, MYFEMBREE, QULIPTA, ABRYSVO, MONOFERRIC, LILETTA.
Industry payments across KS — which companies pay providers there.
